125/DPI (Estropipate 1.5 mg)
Pill with imprint 125/DPI is , and has been identified as Estropipate 1.5 mg. It is supplied by Watson Pharmaceuticals.
Estropipate is used in the treatment of postmenopausal symptoms; atrophic vaginitis; oophorectomy; primary ovarian failure; atrophic urethritis (and more), and belongs to the drug class estrogens. Not for use in pregnancy. Estropipate 1.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 125/DPI
Estropipate
- Imprint:
- 125/DPI
- Strength:
- 1.5 mg
- Availability:
- Prescription only
- Drug Class:
- Estrogens
- Pregnancy Category:
- X - Not for use in pregnancy
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Watson Pharmaceuticals
- National Drug Code (NDC):
- 00364-2601
More about estropipate
- Estropipate Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 3 Reviews
- Drug class: estrogens
Consumer resources
Other brands: Ogen 2.5, Ogen 0.625, Ogen 1.25, Ortho-Est
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
